Franklin Resources’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,953,642
| Closed | -$3.89M | – | 3187 |
|
|
2025
Q2 | $3.89M | Sell |
1,953,642
-3,977
| -0.2% | -$7.27K | ﹤0.01% | 1459 |
|
|
2025
Q1 | $2.84M | Hold |
1,957,619
| – | – | ﹤0.01% | 1572 |
|
|
2024
Q4 | $4.05M | Hold |
1,957,619
| – | – | ﹤0.01% | 1438 |
|
|
2024
Q3 | $3.48M | Sell |
1,957,619
-30,311
| -2% | -$77.7K | ﹤0.01% | 1514 |
|
|
2024
Q2 | $28.7M | Buy |
1,987,930
+133,534
| +7% | +$1.83M | 0.01% | 738 |
|
|
2024
Q1 | $30.8M | Buy |
1,854,396
+8,000
| +0.4% | +$128K | 0.01% | 731 |
|
|
2023
Q4 | $29.6M | Buy |
1,846,396
+71,938
| +4% | +$956K | 0.01% | 653 |
|
|
2023
Q3 | $23.9M | Buy |
1,774,458
+489,908
| +38% | +$6.89M | 0.01% | 697 |
|
|
2023
Q2 | $22.1M | Hold |
1,284,550
| – | – | 0.01% | 735 |
|
|
2023
Q1 | $21.2M | Buy |
1,284,550
+38,409
| +3% | +$614K | 0.01% | 748 |
|
|
2022
Q4 | $20.8M | Buy |
1,246,141
+573,110
| +85% | +$10.3M | 0.01% | 758 |
|
|
2022
Q3 | $11.5M | Buy |
673,031
+519
| +0.1% | +$7.55K | 0.01% | 894 |
|
|
2022
Q2 | $7.35M | Buy |
+672,512
| New | +$7.99M | ﹤0.01% | 1024 |
|
Franklin Resources's HLVX Position: Q3 2025 in Review
Franklin Resources sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 1,953,642 shares — an estimated $3.89M sold.
Franklin Resources first reported a position in HLVX in Q2 2022 and held it in 13 quarters. The position peaked at $30.8M in Q1 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.
- Franklin Resources reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
- Franklin Resources sold 1,953,642 HilleVax shares in Q3 2025, an estimated $3.89M.
- Franklin Resources first reported a position in HilleVax in Q2 2022 and held it in 13 quarters.
- Franklin Resources's HilleVax position peaked at $30.8M in Q1 2024.
- 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.
Based on Franklin Resources's 13F filing for Q3 2025, filed 13 Nov 2025.